WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹219 Cr | ₹153 Cr | ₹413 Cr | ₹-287 Cr | ₹649 Cr |
What is the latest Cash Flow from Operating Activities ratio of WOCKHARDT ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹219 Cr |
Mar2023 | ₹153 Cr |
Mar2022 | ₹413 Cr |
Mar2021 | ₹-287 Cr |
Mar2020 | ₹649 Cr |
How is Cash Flow from Operating Activities of WOCKHARDT Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹219 Cr | 43.14 | |
Mar2023 | ₹153 Cr | -62.95 | |
Mar2022 | ₹413 Cr | Positive | |
Mar2021 | ₹-287 Cr | Negative | |
Mar2020 | ₹649 Cr | - |
Compare Cash Flow from Operating Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹24,463.6 Cr | 4.4% | 22.1% | 180.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 4.4% |
22.1% |
180.8% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses